| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |